Read More Pharma Industry News hVIVO engages in major phase 2b influeness drug study as exclusive UK clinical site hVIVO plc (AIM & Euronext: HVO), a rapidly expanding specialist contract research organisation (CRO) renowned for its expertise… byPallavi MadhirajuJuly 7, 2024